GP also alleviates hepatic steatosis and mitochondrial damage and downregulates the expression of inflammation-related factors, including tumor necrosis factor-alpha (TNF-α) and nuclear factor kappa B (NF-κB) in NAFLD model mice (He et al., 2015). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.